Year archive

Transcenta Holding Limited — 2025 filings

All 52 regulatory filings released by Transcenta Holding Limited (6628) in 2025, sourced directly from the official regulator.

52 Filings

2025 Period

2025 filings (52)

Filing	Released	Lang
GRANT OF AWARD SHARES PURSUANT TO THE SHARE INCENTIVE SCHEME Share Issue/Capital Change	2025-12-29	English
VOLUNTARY ANNOUNCEMENT-TRANSCENTA ANNOUNCES STRATEGIC COLLABORATION AND NON-EXCLUSIVE LICENSING AGREEMENT TO ADVANCE INTEGRATED CONTINUOUS BIOMANUFACTURING AND EXPAND GLOBAL ACCESS TO AFFORDABLE BIOLO Regulatory Filings	2025-12-29	English
VOLUNTARY ANNOUNCEMENT-TRANSCENTA PRESENTS UPDATED EFFICACY DATA FROM THE PHASE I/II TRANSTAR102 TRIAL OF OSEMITAMAB PLUS NIVOLUMAB AND CAPOX IN FIRST-LINE G/GEJ CANCER AT ESMO ASIA Regulatory Filings	2025-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-04	English
GRANT OF AWARD SHARES AND OPTIONS PURSUANT TO THE SHARE INCENTIVE SCHEME Share Issue/Capital Change	2025-11-20	English
CHANGE OF AUDITOR Regulatory Filings	2025-11-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-06	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON TRANSCENTA'S PARTNER INHIBRX REPORTS POSITIVE PHASE 2 RESULTS FOR OZEKIBART IN CHONDROSARCOMA, WITH A BLA SUBMISSION PLANNED FOR 2026 Regulatory Filings	2025-10-30	English
UPDATE ON MEASURES AND ACTIONS TAKEN IN RESOLVING THE DISCLAIMER OF OPINION IN THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 Regulatory Filings	2025-10-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-08	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON STRATEGIC COLLABORATION AGREEMENT WITH IVD MEDICAL HOLDING LIMITED AND ITS TWO SUBSIDIARIES TO EXPLORE FIRST-OF-ITS-KIND OFFERING OF REAL-WORLD ASSET TOKENS T Capital/Financing Update	2025-09-22	English
Next Day Disclosure Returns Share Issue/Capital Change	2025-09-17	English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-09-17	English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS Report Publication Announcement	2025-09-12	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS Report Publication Announcement	2025-09-12	English
2025 INTERIM REPORT Interim / Quarterly Report H1 2025	2025-09-12	English
PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-09-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
(1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025; AND (2) CHANGE IN USE OF PROCEEDS Interim / Quarterly Report H2 2025	2025-08-27	English
DATE OF BOARD MEETING Regulatory Filings	2025-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2025-08-06	English
UPDATE ON MEASURES AND ACTIONS TAKEN IN RESOLVING THE DISCLAIMER OF OPINION IN THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 Regulatory Filings	2025-07-11	English
CLARIFICATION AND SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE GRANT OF OPTIONS PURSUANT TO THE SHARE INCENTIVE SCHEME IN JUNE 2025 Share Issue/Capital Change	2025-07-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Share Issue/Capital Change	2025-07-07	English
GRANT OF AWARD SHARES AND OPTIONS PURSUANT TO THE SHARE INCENTIVE SCHEME Share Issue/Capital Change	2025-06-25	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, JUNE 6, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-05	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON OSEMITAMAB (TST001) FOR G/GEJ CANCER WITH NEW OS DATA FROM FIRST-LINE TRIPLE COMBO TRIAL UNVEILED AT 2025 ASCO ANNUAL MEETING Regulatory Filings	2025-06-02	English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS Report Publication Announcement	2025-05-13	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS Report Publication Announcement	2025-05-13	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 6, 2025 Proxy Solicitation & Information Statement	2025-05-13	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-13	English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES (INCLUDING SALE AND TRANSFER OF TREASURY SHARES) AND NOTICE OF ANNUAL GENERA Proxy Solicitation & Information Statement	2025-05-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Share Issue/Capital Change	2025-05-08	English
VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON PROMISING ANTI-TUMOR ACTIVITY OF NOVEL FGFR2B TARGETING ADC WITH SITE-SPECIFIC CONJUGATED TOPO I INHIBITOR PAYLOAD IN PRECLINICAL TUMOR MODELS AT AACR 2025 Regulatory Filings	2025-04-30	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS Report Publication Announcement	2025-04-22	English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS Report Publication Announcement	2025-04-22	English
2024 Environmental, Social and Governance Report Environmental & Social Information	2025-04-22	English
2024 ANNUAL REPORT Annual Report	2025-04-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Share Issue/Capital Change	2025-04-07	English
GRANT OF AWARD SHARES PURSUANT TO THE SHARE INCENTIVE SCHEME Share Issue/Capital Change	2025-04-02	English
SUPPLEMENTAL ANNOUNCEMENT Regulatory Filings	2025-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024; AND CHANGE IN USE OF PROCEEDS Earnings Release FY 2024	2025-03-30	English
DATE OF BOARD MEETING Regulatory Filings	2025-03-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Share Issue/Capital Change	2025-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-06	English
Next Day Disclosure Returns Transaction in Own Shares	2025-01-14	English
Next Day Disclosure Returns Transaction in Own Shares	2025-01-10	English
Change of Address of Principal Place of Business in Hong Kong Regulatory Filings	2025-01-10	English
Next Day Disclosure Returns Transaction in Own Shares	2025-01-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-07	English
Next Day Disclosure Returns Transaction in Own Shares	2025-01-03	English